CDER?s Division of Post-Marketing Evaluation for Quality Assessment

Article

Special Issues

LCGC SupplementsSpecial Issues-07-01-2006
Volume 0
Issue 0

The new Division of Post Marketing Evaluation in the Office of New Drug Quality Assessment has implemented an improved system for managing the submission and review processes for post approval chemistry, manufacturing, and controls change supplements.

Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Related Content